Real-World Adherence to Biologic Therapy for Severe Asthma in Children. Journal of Allergy and Clinical Immunology: In Practice. 2025; 13(12):3316-3323.
CO41 Children With Asthma Receiving Dupilumab Plus Medium-Dose Inhaled Corticosteroids Had Improved Exacerbations, Lung Function, and Airway Inflammation Compared To Those Receiving Placebo Plus High-Dose Inhaled Corticosteroids. Value in Health. 2025; 28(12):s49.
DUPILUMAB DEMONSTRATED EFFICACY IN CHILDREN WITH ASTHMA AND EARLY CHANGES IN EOSINOPHILS COUNTS. Annals of Allergy, Asthma and Immunology. 2025; 135(5):s51-s52.
EARLY INTERVENTION FOR OPTIMIZING LUNG FUNCTION IN PEDIATRIC ASTHMA: IMPACT OF ON-DEMAND MEDICAL EDUCATION E-LEARNING. Annals of Allergy, Asthma and Immunology. 2025; 135(5):s63.
Pediatric Asthma Impairment and Risk Questionnaire: A Control Assessment for Children Aged 5 to 11 Years. Journal of Allergy and Clinical Immunology: In Practice. 2025; 13(10):2659-2671.
Recurrent Wheezing of Little Lungs: Big Challenges in Understanding Preschool Asthma. Journal of Allergy and Clinical Immunology: In Practice. 2025; 13(10):2588-2589.
Asthma Phenotype Progression in Children and Adolescents: A Single Center Experience. Pediatric Pulmonology. 2025; 60(10):e71319.
Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma Incidence. Journal of Allergy and Clinical Immunology: In Practice. 2025; 13(8):1952-1959.
Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High-Dose ICS in Children With Uncontrolled Moderate-to-Severe Type 2 Asthma. Pediatric Pulmonology. 2025; 60(7):e71197.
Consensus outcomes between health professionals and parents for oral corticosteroids in treating preschool wheeze: a multi-national survey and nominal group technique study. Archives of Disease in Childhood. 2025; 110(7):521-527.
Epinephrine Prescription and Post-injection Monitoring Practices for Biologic Therapies in Pediatric Severe Asthma Clinics: A Multicenter Survey Analysis. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a2264-a2264.
Current Practices Among 13 Severe Pediatric Asthma Programs in the United States. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Abstracts):a2249-a2249.
Performance of the Pediatric Asthma Impairment and Risk Questionnaire (Peds-AIRQ) in Assessing Control Relative to the Pediatric Quality of Life Inventory (PedsQL) and Patient Impression of Control. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a5022-a5022.
Dupilumab Reduces Exacerbations and Improves Asthma Control in Children Regardless of Asthma Duration. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a1374-a1374.
Performance of the Pediatric Asthma Impairment and Risk Questionnaire (Peds-AIRQ) in Assessing Control for Children With Asthma Aged 5 to 11 Years. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a1288-a1288.
Dupilumab plus medium-dose inhaled corticosteroid improves outcomes compared with placebo plus high-dose inhaled corticosteroid in pediatric patients with uncontrolled asthma. Klinische Padiatrie. 2025; 237(02):s2-s2.
Dupilumab Induces Clinical Remission in Children with Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma. Klinische Padiatrie. 2025; 237(02):s1-s2.
Rémission clinique avec le dupilumab chez les enfants atteints d’asthme de type 2 non contrôlé, modéré à sévère. Perfectionnement en Pédiatrie. 2025; 8(1):84.
Race-Specific and Race-Neutral Equations for Lung Function and Asthma Diagnosis in Black Children. JAMA Network Open. 2025; 8(2):e2462176.
Vitamin D Supplementation, Long-Term PM2.5 Exposure, and Severe Asthma Exacerbations in Children with Low Vitamin D: A Post Hoc Analysis of a Double-Blind, Randomized, Placebo-controlled Trial (VDKA). American Journal of Respiratory and Critical Care Medicine. 2025; 211(2):266-268.
Pediatric Asthma Impairment and Risk Questionnaire: Rationale and development of a composite control tool. Annals of Allergy, Asthma and Immunology. 2025; 134(2):198-208.e2.
Performance Of Asthma Control Assessments in Detecting Impairment And Risk In Demographically Diverse Children Aged 5-11 Years. Journal of Allergy and Clinical Immunology. 2025; 155(2):ab105.
Outcomes and Recommendations From Telehealth Asthma Clinics in Underserved Schools. Pediatric Pulmonology. 2025; 60(2):e71003.
Disparities in adolescent controller medication adherence, treatment barriers, and asthma control. Pediatric Pulmonology. 2024; 59(12):3288-3297.
DUPILUMAB PLUS MEDIUM-DOSE INHALED CORTICOSTEROID IMPROVES OUTCOMES COMPARED WITH PLACEBO PLUS HIGH-DOSE INHALED CORTICOSTEROID IN PEDIATRIC PATIENTS WITH UNCONTROLLED ASTHMA. Chest. 2024; 166(4):a4806-a4808.
Impulse oscillometry: Gathering speed in the assessment of preschool lung function. Journal of Allergy and Clinical Immunology. 2024; 154(1):82-83.
Efficacy of oral corticosteroids for acute preschool wheeze: a systematic review and individual participant data meta-analysis of randomised clinical trials. The Lancet Respiratory Medicine. 2024; 12(6):444-456.
Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study. Journal of Allergy and Clinical Immunology: In Practice. 2024; 12(4):948-959.
Long-term dupilumab effect on lung function in paediatric patients with uncontrolled asthma. Pneumologie. 2024; 78:s7-s7.
Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study). Pediatric Allergy and Immunology. 2024; 35(3):e14092.
Climate Change and Children's Health: Building a Healthy Future for Every Child. Pediatrics. 2024; 153(3).
Long-term dupilumab effect on lung function in paediatric patients with uncontrolled asthma. Klinische Padiatrie. 2024; 236(02):s2-s3.
Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension study. The Lancet Respiratory Medicine. 2024; 12(1):45-54.
Effet à long terme du dupilumab sur la fonction respiratoire chez des patients pédiatriques souffrant d’asthme non contrôlé Revue des Maladies Respiratoires Actualites. 2024; 16(1):185.
Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study. Journal of Asthma and Allergy. 2024; 17:81-87.
Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study. Journal of Asthma and Allergy. 2024; 17:143-159.
LONG-TERM DUPILUMAB EFFECT ON LUNG FUNCTION IN MULTIPLE SUBGROUPS OF PEDIATRIC PATIENTS WITH UNCONTROLLED ASTHMA. Chest. 2023; 164(4):a40-a44.
Long-Term Exposure to Particulate Matter <2.5 μm and Lung Function Change in Children with Asthma Receiving Inhaled Corticosteroids. American Journal of Respiratory and Critical Care Medicine. 2023; 208(5):622-624.
How Has the Biologic Revolution Improved Patient Care? Journal of Allergy and Clinical Immunology: In Practice. 2023; 11(9):2683-2685.
Children with uncontrolled asthma from economically disadvantaged neighborhoods: Needs assessment and the development of a school-based telehealth and electronic inhaler monitoring system. Pediatric Pulmonology. 2023; 58(8):2249-2259.
Technology-Assisted Stepped-Care to Promote Adherence in Adolescents with Asthma: A Pilot Study. Journal of Clinical Psychology in Medical Settings. 2023; 30(2):415-424.
Questions in Mild Asthma: An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine. 2023; 207(11):e77-e96.
Long-Term Dupilumab Treatment Effect On Safety And Clinical Efficacy In Children With Type 2 Asthma: LIBERTY ASTHMA EXCURSION. Journal of Allergy and Clinical Immunology. 2023; 151(2):ab15.
Impact Of Exacerbation History On Dupilumab Efficacy In Children With Asthma In The VOYAGE Study. Journal of Allergy and Clinical Immunology. 2023; 151(2):ab19.
Asthma Management in Children. Journal of Allergy and Clinical Immunology: In Practice. 2023; 11(1):9-18.
ASSESSMENT OF THE LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN CHILDREN WITH ASTHMA (LIBERTY ASTHMA EXCURSION STUDY) Chest. 2022; 162(4):a2677-a2679.
Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma. npj Primary Care Respiratory Medicine. 2022; 32(1):31.
Violence-related distress and lung function in two longitudinal studies of youth. European Respiratory Journal. 2022; 59(5).
Treatment by biomarker-informed endotype vs guideline care in children with difficult-to-treat asthma. Annals of Allergy, Asthma and Immunology. 2022; 128(5):535-543.e6.
Key Issues in Pediatric and Adult Severe Asthma: Staying Grounded as Biologics Take Us to New Heights. Journal of Allergy and Clinical Immunology: In Practice. 2022; 10(2):420-421.
Effect of vitamin D supplementation on total and allergen-specific IgE in children with asthma and low vitamin D levels. Journal of Allergy and Clinical Immunology. 2022; 149(1):440-444.e2.
Evaluation of Risk Scores to Predict Pediatric Severe Asthma Exacerbations. Journal of Allergy and Clinical Immunology: In Practice. 2021; 9(12):4393-4401.e8.
Feasibility and preliminary validity of mobile spirometry in pediatric asthma. Journal of Allergy and Clinical Immunology: In Practice. 2021; 9(10):3821-3823.
Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal. 2021; 58(4).
Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: the VDKA randomized clinical trial. . 2021.
Which Wheezing Preschoolers Should be Treated for Asthma? Journal of Allergy and Clinical Immunology: In Practice. 2021; 9(7):2611-2618.
129Xe MRI as a measure of clinical disease severity for pediatric asthma. Journal of Allergy and Clinical Immunology. 2021; 147(6):2146-2153.e1.
Nasal DNA methylation differentiates severe from non-severe asthma in African-American children. Allergy. European Journal of Allergy and Clinical Immunology. 2021; 76(6):1836-1845.
Use of the composite asthma severity index in a pediatric subspecialty clinic. Annals of Allergy, Asthma and Immunology. 2021; 126(6):702-706.
Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation. Contemporary Clinical Trials. 2021; 100:106228.
Exciting Era of Sensor-Based Electronic Monitoring of Adherence in Pediatric Asthma. Pediatrics. 2021; 147(1).
Bronchial Thermoplasty. In: Diagnostic and Interventional Bronchoscopy in Children. Springer Nature; 2021:477-485.